Aldeyra Therapeutics (ALDX) Tops Q3 EPS by 1c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Worthington Industries (WOR) Misses Q4 EPS by 9c